Low testosterone levels may increase the risk of higher-grade “extreme” progression of prostate cancer among men enrolled in active surveillance (AS), acc ...

A randomized crossover pilot study conducted by researchers at the University of Sherbrooke and the Research Centre on Aging in Quebec, Canada ...

Many patients with cancer cite lack of energy as a significant barrier to healthy living with proper diet and exercise, but ...

This may not apply in your husband’s case, but it’s worth having the conversation. The two meds Goldstein prescribes for men are flibanserin (Addyi), an oral tablet taken d ...

UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

Patients with cancer undergoing individually tailored exercise intervention also reported less mental fatigue.

Pfizer (PFE) stock is in focus as Xtandi, marketed with Astellas (ALPMF), and cancer drug Talzenna succeed in a Phase 3 trial for prostate cancer. Read more here.

By Tim BakerClose readers of this blog and, indeed, the PCFA website, may have picked up on the carefully guarded secret that I have written a book ...

A consultant urological surgeon has explained why you need to prepare before a cancer check ...

Historically, treatment for metastatic prostate cancer relied heavily on androgen deprivation therapy (ADT) alone. Over time, research has demonstrated that combining ADT with additional agents ...

Men with aggressive prostate cancer, often left with few options after chemotherapy fails, now have access to a new treatment that uses a radioactive substance.The new treatment, Lutetium-177 PSMA ...